Biodexa Pharmaceuticals Stock (NASDAQ: BDRX) stock price, news, charts, stock research, profile.
Open | $1.660 |
Close | $1.300 |
Volume / Avg. | 70.820M / 2.064M |
Day Range | 1.140 - 1.740 |
52 Wk Range | 0.670 - 21.440 |
Market Cap | $5.350M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 59 |
Short Interest | 1.52% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Biodexa Pharmaceuticals (NASDAQ: BDRX) through any online brokerage.
Other companies in Biodexa Pharmaceuticals’s space includes: Tharimmune (NASDAQ:THAR), Dermata Therapeutics (NASDAQ:DRMA), Quoin Pharmaceuticals (NASDAQ:QNRX), Cyclacel Pharmaceuticals (NASDAQ:CYCC) and Geovax Labs (NASDAQ:GOVX).
The latest price target for Biodexa Pharmaceuticals (NASDAQ: BDRX) was reported by Ladenburg Thalmann on Thursday, February 8, 2024. The analyst firm set a price target for 8.00 expecting BDRX to rise to within 12 months (a possible 555.74% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Biodexa Pharmaceuticals (NASDAQ: BDRX) is $1.22 last updated April 26, 2024 at 7:59 PM EDT.
There are no upcoming dividends for Biodexa Pharmaceuticals.
Biodexa Pharmaceuticals’s FY earnings are confirmed for Friday, May 10, 2024.
There is no upcoming split for Biodexa Pharmaceuticals.
Biodexa Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.